Rat Apolipoprotein A-IV(APOA4) ELISA kit
-
中文名稱:大鼠載脂蛋白A-IV(APOA4)酶聯(lián)免疫試劑盒
-
貨號(hào):CSB-EL001916RA
-
規(guī)格:96T/48T
-
價(jià)格:¥3600/¥2500
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:大鼠載脂蛋白A-IV(APOA4)酶聯(lián)免疫試劑盒(CSB-EL001916RA)為雙抗夾心法ELISA試劑盒,定量檢測(cè)血清、血漿、組織勻漿樣本中的APOA4含量。APOA4 是一個(gè)重要靶點(diǎn)。它在脂質(zhì)代謝、心血管疾病等方面有重要作用。其研究機(jī)制主要聚焦于它在脂蛋白合成與代謝中的功能,以及它對(duì)炎癥反應(yīng)、氧化應(yīng)激的調(diào)節(jié)等,探索其與疾病發(fā)生發(fā)展關(guān)聯(lián),為相關(guān)疾病治療提供思路。試劑盒檢測(cè)范圍為9.38 ng/mL-600 ng/mL,適用于肥胖、高脂血癥、動(dòng)脈粥樣硬化等代謝性疾病模型的機(jī)制研究,也可用于評(píng)估藥物或飲食干預(yù)對(duì)脂代謝通路的影響,滿足心血管、內(nèi)分泌等領(lǐng)域的科研需求本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見(jiàn)產(chǎn)品說(shuō)明書(shū)。
-
別名:Apoa4Apolipoprotein A-IV ELISA kit; Apo-AIV ELISA kit; ApoA-IV ELISA kit; Apolipoprotein A4 ELISA kit
-
縮寫(xiě):APOA4
-
Uniprot No.:
-
種屬:Rattus norvegicus (Rat)
-
樣本類型:serum, plasma, tissue homogenates
-
檢測(cè)范圍:9.38 ng/mL-600 ng/mL
-
靈敏度:2.34 ng/mL
-
反應(yīng)時(shí)間:1-5h
-
樣本體積:50-100ul
-
檢測(cè)波長(zhǎng):450 nm
-
研究領(lǐng)域:Cancer
-
測(cè)定原理:quantitative
-
測(cè)定方法:Sandwich
-
精密度:
Intra-assay Precision (Precision within an assay): CV%<8% Three samples of known concentration were tested twenty times on one plate to assess. Inter-assay Precision (Precision between assays): CV%<10% Three samples of known concentration were tested in twenty assays to assess. -
線性度:
To assess the linearity of the assay, samples were spiked with high concentrations of rat APOA4 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. Sample Serum(n=4) 1:200 Average % 93 Range % 87-97 1:400 Average % 101 Range % 97-105 1:800 Average % 92 Range % 88-96 1:1600 Average % 95 Range % 91-101 -
回收率:
The recovery of rat APOA4 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. Sample Type Average % Recovery Range Serum (n=5) 94 89-98 EDTA plasma (n=4) 89 83-94 -
標(biāo)準(zhǔn)曲線:
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. ng/ml OD1 OD2 Average Corrected 600 2.567 2.615 2.591 2.454 300 1.934 2.078 2.006 1.869 150 1.324 1.397 1.361 1.224 75 0.831 0.822 0.827 0.690 37.5 0.581 0.574 0.578 0.441 18.75 0.334 0.323 0.329 0.192 9.38 0.261 0.268 0.265 0.128 0 0.136 0.137 0.137 -
數(shù)據(jù)處理:
-
貨期:3-5 working days
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能:May have a role in chylomicrons and VLDL secretion and catabolism. Required for efficient activation of lipoprotein lipase by ApoC-II; potent activator of LCAT. Apoa-IV is a major component of HDL and chylomicrons.
-
基因功能參考文獻(xiàn):
- demonstrate a critical role of the PI3K/Akt pathway in apoA-IV's anorectic action in lean rats and suggest a defective PI3K pathway in the ventromedial hypothalamus is responsible for the impaired apoA-IV's anorectic action in the diet-induced obese animals PMID: 29037812
- These results suggest that the elevated mRNA expression levels of Rbp2 and Apoa4 in the rats with SB contribute to the effective esterification and transport of vitamin A. PMID: 25585692
- Compared to the rats in the control group, the rats in the HF group had the expression levels of 12 genes with significant changes, Agrp, Ghrl, and Nr3c1, Apoa4, Cntf, Ghr, IL-1beta, Ins1, Lepr,Sort, Adcyap1r1 and Adrb1. PMID: 22715380
- Nuclear ERalpha is the primary mediator of E2's action on apo A-IV gene expression. PMID: 25051443
- Data suggest that apoAIV in NTS (nucleus of the solitary tract) or/and peripheral Cck (cholecystokinin) require vagal Cck1r (cholecystokinin receptor 1) signaling to elicit satiation; high-fat diet reduces satiating capacity of these signals. PMID: 24564397
- Octreotide intervention down-regulated expression of apoB mRNA and apoB48 protein, as well as MTP mRNA and proteins. ApoAIV mRNA was not significantly different between obese and octreotide-treated rats. PMID: 23911221
- peripheral apo AIV requires an intact CCK system and vagal afferents to activate neurons in the hindbrain to reduce food intake PMID: 23027805
- hypothalamic apo A-IV level and food intake were inversely related during the normal diurnal cycle as well as in the period of restricted feeding suggesting that hypothalamic apo A-IV is involved in the regulation of daily food intake. PMID: 15059955
- Chronic consumption of a high fat diet significantly reduced apolipoprotein A-IV (apo A-IV) mRNA levels and response of apo A-IV gene expression to dietary lipids in the hypothalamus. PMID: 15082422
- apo A-IV released from the intestinal mucosa during lipid absorption stimulates the release of endogenous CCK that activates CCK(1) receptors on vagal afferent nerve terminals initiating feedback inhibition of gastric motility. PMID: 15117731
- data support a synergistic interaction between apo A-IV and melanocortins that reduces food intake by acting downstream of the arcuate PMID: 16166201
- that apo A-IV, produced by neuronal cells iin brain, may exert its anorectic action by interacting with catabolic regulatory neuropeptides. PMID: 18577393
- Intraperitoneally injected Apoa4 inhibited food intake and levels were measured in intestinal lymph. PMID: 19020287
顯示更多
收起更多
-
亞細(xì)胞定位:Secreted.
-
蛋白家族:Apolipoprotein A1/A4/E family
-
組織特異性:Secreted in plasma.
-
數(shù)據(jù)庫(kù)鏈接:
Most popular with customers
-
Human Transforming Growth factor β1,TGF-β1 ELISA kit
Detect Range: 23.5 pg/ml-1500 pg/ml
Sensitivity: 5.8 pg/ml
-
-
-
Mouse Tumor necrosis factor α,TNF-α ELISA Kit
Detect Range: 7.8 pg/ml-500 pg/ml
Sensitivity: 1.95 pg/ml
-
-
-
-